Conducting Clinical Trials With Decentralized Elements
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 18, 2024
September 18, 2024
dc054f22-ff9d-4ea3-8083-fe59c7622408
Related Documents
Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
Guidance DocumentMay 26, 2023Center for Drug Evaluation and Research
Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
Guidance DocumentDecember 22, 2023Center for Drug Evaluation and Research
Evaluating Cancer Drugs in Patients with Central Nervous System Metastases: Guidance for Industry
Guidance DocumentJuly 1, 2021Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox